- Advertisement -
- Advertisement -
- Advertisement -

Find a job

Subscribe for free

All things Pharma

Global Pharma

A global view of pharma and healthcare and its impact on UK industry.

LATEST >

Empagliflozin approved in the EU for the treatment of chronic kidney disease

The European Commission (EC) has approved Boehringer Ingelheim and Eli Lilly’s Jardiance® (empagliflozin) for the treatment of adults with chronic kidney disease (CKD). The approval...
- Advertisement -
- Advertisement -

MOST READ > NEWS

Subscribe

Sign up to receive our digital newsletter, for all the essential headlines, Jobs of the Week and thought-provoking features.

Claim my free subscription